Isatin Derivatives as Human Intestinal Carboxylesterase Inhibitors: An Approach towards 3D-QSAR, Pharmacophore and Molecular Docking
Carboxylesterases (CEs) metabolise a variety of medications, and inhibiting them can increase the bioactivity or reduce the toxicity of substances activated by these enzymes. Isatin...